KR850005449A - 메틸렌디포스폰산 유도체의 제조방법 - Google Patents

메틸렌디포스폰산 유도체의 제조방법 Download PDF

Info

Publication number
KR850005449A
KR850005449A KR1019850000466A KR850000466A KR850005449A KR 850005449 A KR850005449 A KR 850005449A KR 1019850000466 A KR1019850000466 A KR 1019850000466A KR 850000466 A KR850000466 A KR 850000466A KR 850005449 A KR850005449 A KR 850005449A
Authority
KR
South Korea
Prior art keywords
group
alkyl group
formula
alk
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019850000466A
Other languages
English (en)
Korean (ko)
Inventor
바르비에르(외 2) 알렝
Original Assignee
미쉘드아스
소시에떼 아노님 사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 미쉘드아스, 소시에떼 아노님 사노피 filed Critical 미쉘드아스
Publication of KR850005449A publication Critical patent/KR850005449A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Fireproofing Substances (AREA)
KR1019850000466A 1984-01-26 1985-01-25 메틸렌디포스폰산 유도체의 제조방법 Withdrawn KR850005449A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8401214A FR2558837B1 (fr) 1984-01-26 1984-01-26 Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
FR8401214 1984-01-26

Publications (1)

Publication Number Publication Date
KR850005449A true KR850005449A (ko) 1985-08-26

Family

ID=9300506

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850000466A Withdrawn KR850005449A (ko) 1984-01-26 1985-01-25 메틸렌디포스폰산 유도체의 제조방법

Country Status (30)

Country Link
US (1) US4876247A (enExample)
EP (1) EP0151072B1 (enExample)
JP (1) JPS60174792A (enExample)
KR (1) KR850005449A (enExample)
AT (1) ATE32900T1 (enExample)
AU (1) AU570764B2 (enExample)
CA (1) CA1263397A (enExample)
CS (2) CS247192B2 (enExample)
DD (1) DD233847A5 (enExample)
DE (1) DE3561819D1 (enExample)
DK (1) DK168573B1 (enExample)
EG (1) EG16903A (enExample)
ES (1) ES8602028A1 (enExample)
FI (1) FI77664C (enExample)
FR (1) FR2558837B1 (enExample)
GR (1) GR850160B (enExample)
HU (1) HU192664B (enExample)
IE (1) IE57971B1 (enExample)
IL (1) IL74117A (enExample)
MA (1) MA20331A1 (enExample)
NO (1) NO161678C (enExample)
NZ (1) NZ210945A (enExample)
OA (1) OA07941A (enExample)
PH (1) PH20913A (enExample)
PL (3) PL148892B1 (enExample)
PT (1) PT79859B (enExample)
SG (1) SG43289G (enExample)
SU (3) SU1382402A3 (enExample)
YU (2) YU11785A (enExample)
ZA (1) ZA85390B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates
IL84731A0 (en) * 1986-12-19 1988-05-31 Norwich Eaton Pharma Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
DE69116838T2 (de) * 1990-12-19 1996-06-13 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung
DE69225325T2 (de) * 1991-09-05 1998-08-27 Toray Industries Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
NZ253524A (en) * 1992-05-29 1997-01-29 Procter & Gamble Pharma Sulphur-containing phosphonate derivatives and medicaments (for treating abnormal calcium and phosphate metabolism)
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
PL175046B1 (pl) * 1992-05-29 1998-10-30 Procter & Gamble Pharma Nowe tio-podstawione, zawierające azot heterocykliczne związki fosfonianowe
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
SK144894A3 (en) * 1992-05-29 1995-07-11 Procter & Gamble Pharma Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
DK0650361T3 (da) * 1992-06-30 1999-06-23 Procter & Gamble Pharma Sammensætninger til behandling af arthritis, hvilke sammensætninger indeholder phosphonater og NSAID'er
KR100272907B1 (ko) * 1992-07-10 2001-03-02 히라이 가쯔히꼬 메탄디포스폰산 유도체, 이의 제조방법 및 이의 의약 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1958123C3 (de) * 1969-11-19 1978-09-28 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen
DE2115737C3 (de) * 1971-03-31 1979-11-08 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 - Aminoalkan-1,1 -diphosphonsäuren
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4100167A (en) * 1977-05-09 1978-07-11 Nalco Chemical Company Production of 1-aminoalkane-1, 1-diphosphonic acids using phosphorous acid and nitriles in a non-aqueous system
DE2754821C3 (de) * 1977-12-09 1981-08-13 Benckiser-Knapsack Gmbh, 6802 Ladenburg Verfahren zur Herstellung von 1-Aminoalkan-1,1-diphosphonsäuren
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation

Also Published As

Publication number Publication date
OA07941A (fr) 1987-01-31
FI850319A0 (fi) 1985-01-24
FI77664B (fi) 1988-12-30
PL251700A1 (en) 1985-09-10
SU1419520A3 (ru) 1988-08-23
CS247192B2 (en) 1986-12-18
PH20913A (en) 1987-05-28
SG43289G (en) 1989-12-22
NO850315L (no) 1985-07-29
DD233847A5 (de) 1986-03-12
YU113787A (en) 1988-04-30
CA1263397A (en) 1989-11-28
DK168573B1 (da) 1994-04-25
IL74117A (en) 1989-02-28
IE850140L (en) 1985-07-26
HU192664B (en) 1987-06-29
GR850160B (enExample) 1985-05-23
PL144353B1 (en) 1988-05-31
AU3794085A (en) 1985-08-01
PL142493B1 (en) 1987-10-31
PL148892B1 (en) 1989-12-30
PT79859A (fr) 1985-02-01
FR2558837B1 (fr) 1986-06-27
IL74117A0 (en) 1985-04-30
NZ210945A (en) 1987-06-30
ATE32900T1 (de) 1988-03-15
FR2558837A1 (fr) 1985-08-02
FI77664C (fi) 1989-04-10
PT79859B (fr) 1986-10-23
MA20331A1 (fr) 1985-10-01
DK29285D0 (da) 1985-01-22
NO161678C (no) 1989-09-13
HUT38362A (en) 1986-05-28
ES539833A0 (es) 1985-11-16
NO161678B (no) 1989-06-05
ES8602028A1 (es) 1985-11-16
FI850319L (fi) 1985-07-27
US4876247A (en) 1989-10-24
DE3561819D1 (en) 1988-04-14
EG16903A (en) 1989-06-30
JPH0455436B2 (enExample) 1992-09-03
YU11785A (en) 1987-12-31
JPS60174792A (ja) 1985-09-09
DK29285A (da) 1985-07-27
EP0151072A3 (en) 1985-08-21
ZA85390B (en) 1985-08-28
SU1410865A3 (ru) 1988-07-15
SU1382402A3 (ru) 1988-03-15
EP0151072B1 (fr) 1988-03-09
CS247199B2 (en) 1986-12-18
IE57971B1 (en) 1993-06-02
EP0151072A2 (fr) 1985-08-07
AU570764B2 (en) 1988-03-24

Similar Documents

Publication Publication Date Title
KR850005449A (ko) 메틸렌디포스폰산 유도체의 제조방법
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR850006404A (ko) 니트로 메틸렌 유도체의 제조방법
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
ES8306753A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
KR850002269A (ko) 피리도인돌 유도체의 제조방법
KR840001177A (ko) 제초제인 설폰아미드의 제조방법
EA199700432A1 (ru) Способ получения 2-пирролидонил-3-эфиров, тиоэфиров и амидов (тио-)угольной/карбаминовой кислоты
KR860001048A (ko) 플루오로알릴아민 유도체의 제조방법
KR830005110A (ko) 플루오렌 유도체의 제조방법
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
KR840004065A (ko) 2-시아노-2-프로페노산 및 그 유도체의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR840009096A (ko) 이치환 폴리에틸렌 이민의 제조방법
KR830003460A (ko) 면역조절 활성을 갖는 치환된 피페라진 및 피페리딘
HUP9800869A1 (hu) Eljárás klór-ketoaminok előállítására karbamátok alkalmazásával
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR860003245A (ko) 중추신경계에 특효가 있는 티아디아졸 유도체의 제조방법
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850006397A (ko) 치환된 이소크로만 및 옥세핀의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19850125

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid